ArticleBioarchitecture2011
Scared stiff: Stabilizing the actin cytoskeleton to stop invading cancer cells in their tracks.
Article in Bioarchitecture, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Tropomyosin 2.1 collaborates with fibronectin to promote TGF-βRespiratory research · 2021Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In recent years the concept of plasticity between invasion modes used by individual cancer cells has been gaining increasing interest in the field. Individually invading tumour cells can be divided into those that use a mesenchymal invasion mode, those that use "amoeboid" invasion and those that can switch between the two modes. The morphological distinctions between these different modes of invasion suggest that the actin cytoskeleton is likely to be a major contributor to the plasticity of cancer cell invasion mechanisms. We have recently investigated this idea by manipulating expression of Tm5NM1, one isoform of the tropomyosin family of actin-associating proteins. In a novel finding, we discovered that stabilizing the actin cytoskeleton via elevated expression of Tm5NM1 specifically inhibits mesenchymal-type cancer cell invasion, without causing transition to "amoeboid" motility-thus stopping the invading cancer cells in their tracks. The present perspective discusses our recent data in the context of current understanding of invasion plasticity and considers how stabilizing actin filaments may inhibit the mesenchymal invasion mode.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.